Hispanic
Black and Hispanic Patients Were More Likely to Delay Cancer Pharmacotherapy During the COVID-19 Pandemic
During the COVID-19 pandemic, ethnicity and area-level social determents of health were associated with delays in or discontinuation of treatment f...
Understanding the role of access in Hispanic cancer screening disparities
Background:
Hispanic populations in the United States experience numerous barriers to care access. It is unclear how cancer screenin...
Excess risk of chronic health conditions in Hispanic survivors of adolescent and young adult cancers
Purpose:
There is a growing population of survivors of adolescent and young adult (AYA) cancers (age 15-39 years at diagnosis). Stud...
Black and Hispanic patients treated for retinal detachment with surgery had worse vision results than white patients
This study, performed in an environment with universal health care, reveals that race and ethnicity may impact both the presentation and outcomes o...
Black, Hispanic patients with cancer more likely to report negative care experiences, bias
January 18, 2023
4 min read
Source/Disclosures
Published by:
...
Black and hispanic women have less support during cancer evaluation and treatment: results from a prospective patient reported outcomes program in ...
Objective:
Race remains a significant predictor of poor outcomes in women with gynecologic cancer and minority patients consistently...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
